​ Conditions: Glioblastoma; High-Grade Glioma (WHO III-IV); High-grade Glioma; Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Hemispheric Glioma, H3G34 Mutant

Interventions: Drug: ADI-PEG 20 (Arginine deiminase pegylated); Drug: Temozolomide (TMZ); Radiation: Standard of Care Radiation Therapy (RT)

Sponsors: Sabine Mueller, MD, PhD

Not yet recruiting Conditions: Glioblastoma; High-Grade Glioma (WHO III-IV); High-grade Glioma; Diffuse Midline Glioma, H3 K27M-Mutant; Diffuse Hemispheric Glioma, H3G34 Mutant
Interventions: Drug: ADI-PEG 20 (Arginine deiminase pegylated); Drug: Temozolomide (TMZ); Radiation: Standard of Care Radiation Therapy (RT)
Sponsors: Sabine Mueller, MD, PhD
Not yet recruiting